insulin drugs glp 1 receptor agaonist market GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Growth
Description
Samms RJ, Zhang G, He W, et al
Back Finkelstein, EA, Trogdon, JG, Cohen, JW (2009) 'Annual medical spending attributable to obesity: payer-and service-specific estimates', Health Affairs , 28/5, w82231
doi: 10.1016/j.cgh.2024.03.006
Clinical studies and meta-analyses have identified an increased risk of gallbladder disease with GLP-1 receptor agonist use, particularly with weight loss medications
conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate
